Cargando…

Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction

Breast cancer (BC) is a complex disease comprising multiple distinct subtypes with different genetic features and pathological characteristics. Although a large number of antineoplastic compounds have been approved for clinical use, patient-to-patient variability in drug response is frequently obser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xinsong, Sifakis, Emmanouil G., Robertson, Stephanie, Neo, Shi Yong, Jun, Seong-Hwan, Tong, Le, Hui Min, Apple Tay, Lövrot, John, Hellgren, Roxanna, Margolin, Sara, Bergh, Jonas, Foukakis, Theodoros, Lagergren, Jens, Lundqvist, Andreas, Ma, Ran, Hartman, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2022
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910599/ https://www.ncbi.nlm.nih.gov/pubmed/36574653 http://dx.doi.org/10.1073/pnas.2209856120

Ejemplares similares

PD-1 protein and gene expression as prognostic factors in early breast cancer
por: Matikas, Alexios, et al.
Publicado: (2020)

Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen receptor‐positive disease
por: Zerdes, Ioannis, et al.
Publicado: (2020)

Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer
por: Matikas, Alexios, et al.
Publicado: (2018)

The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours
por: Lundberg, Arian, et al.
Publicado: (2019)

STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer
por: Zerdes, Ioannis, et al.
Publicado: (2019)

Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling
por: Karthik, Govindasamy-Muralidharan, et al.
Publicado: (2017)

Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics
por: Jun, Seong-Hwan, et al.
Publicado: (2023)

Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy
por: Chrétien, Sebastian, et al.
Publicado: (2019)

A(2B) adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models
por: Tay, Apple Hui Min, et al.
Publicado: (2022)

Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations
por: Zerdes, Ioannis, et al.
Publicado: (2018)

Women with short survival after diagnosis of metastatic breast cancer: a population-based registry study
por: Boman, Caroline, et al.
Publicado: (2022)

An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
por: Palazon, Asis, et al.
Publicado: (2017)

Immune gene expression and response to chemotherapy in advanced breast cancer
por: Foukakis, Theodoros, et al.
Publicado: (2018)

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies
por: Milosevic, Jelena, et al.
Publicado: (2013)

Expression patterns and prognostic implications of tumor-infiltrating lymphocytes dynamics in early breast cancer patients receiving neoadjuvant therapy: A systematic review and meta-analysis
por: Zhu, Yajing, et al.
Publicado: (2022)

Validation of a novel procedure for quantification of the formation of phosphoramide mustard by individuals treated with cyclophosphamide
por: von Stedingk, Hans, et al.
Publicado: (2014)

Chemotherapy use near the end-of-life in patients with metastatic breast cancer
por: Edman Kessler, Luisa, et al.
Publicado: (2020)

Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer
por: Brandberg, Yvonne, et al.
Publicado: (2020)

Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter Study
por: Kjällquist, Una, et al.
Publicado: (2022)

Dissecting Tumor-Immune Microenvironment in Breast Cancer at a Spatial and Multiplex Resolution
por: Tzoras, Evangelos, et al.
Publicado: (2022)

Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer
por: Matikas, Alexios, et al.
Publicado: (2017)

Avoiding over- and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet?
por: Matikas, A, et al.
Publicado: (2019)

Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study
por: Zerdes, Ioannis, et al.
Publicado: (2021)

The Importance of Sex in the Discovery of Colorectal Cancer Prognostic Biomarkers
por: Hases, Linnea, et al.
Publicado: (2021)

Solid-phase capture and profiling of open chromatin by spatial ATAC
por: Llorens-Bobadilla, Enric, et al.
Publicado: (2023)

Time to Mammographic Density Decrease After Exposure to Tamoxifen
por: Bäcklund, Magnus, et al.
Publicado: (2022)

NK cells and solid tumors: therapeutic potential and persisting obstacles
por: Tong, Le, et al.
Publicado: (2022)

Inferring tumor progression in large datasets
por: Mohaghegh Neyshabouri, Mohammadreza, et al.
Publicado: (2020)

Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer
por: Zerdes, Ioannis, et al.
Publicado: (2021)

Development and characterization of a recombinant silk network for 3D culture of immortalized and fresh tumor‐derived breast cancer cells
por: Collodet, Caterina, et al.
Publicado: (2023)

Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo
por: Klevebring, Daniel, et al.
Publicado: (2014)

The interplay between eosinophils and T cells in breast cancer immunotherapy
por: Zerdes, Ioannis, et al.
Publicado: (2023)

Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells
por: Ma, Ran, et al.
Publicado: (2017)

Adherence to endocrine therapy in early breast cancer in relation to Cytochrome P450 2D6 genotype: a comparison between pharmacy dispensation data and medical records
por: Thorén, Linda, et al.
Publicado: (2023)

aThe dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancer
por: Rosin, Gustaf, et al.
Publicado: (2012)

Predictors of mammographic microcalcifications
por: Azam, Shadi, et al.
Publicado: (2020)

Mammographic microcalcifications and risk of breast cancer
por: Azam, Shadi, et al.
Publicado: (2021)

Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing
por: Bartoschek, Michael, et al.
Publicado: (2018)

Does three-dimensional functional infrared imaging improve breast cancer detection based on digital mammography in women with dense breasts?
por: Hellgren, Roxanna J., et al.
Publicado: (2019)

The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI
por: Hellgren, Roxanna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3nno7cmkl4pqbvi4bd1jmebgc6